Search Results

with >15 days from diagnosis to treatment initiation (DTI) had lower-risk characteristics and improved event-free survival (EFS) at 24 months from diagnosis compared with patients treated more urgently. Furthermore, a retrospective, observational study

version 3.4.4 (R Foundation for Statistical Computing). Univariate and multivariable regression were performed using SAS 9.4 (SAS Institute Inc) to evaluate the associations between clinical characteristics and anemia prevalence, evaluation, and treatment

date of last follow-up were censored on that date. The patient characteristics were analyzed using descriptive statistics. Survival functions were estimated using the Kaplan-Meier method. Results Demographics From July 2010 to December

patients receive chemotherapy with paclitaxel and carboplatin. In early-stage nonserous epithelial ovarian cancer, 3 cycles have been shown to be as effective as 6 Figure 1. Characteristics of ovarian cancer subtypes. Abbreviation: MP

characteristics, type of malignancy, and survival duration; however, it did not provide information on patient symptoms, performance status, cytogenetics, MRD, treatment drugs, stem cell transplantation, or other prognostic factors. Selection criteria for this

after cancer diagnosis. Regional Covariates This study evaluated the association between the regional use of cancer-related palliative care and regional health care characteristics. Regional geography was evaluated at the level of hospital

molecular biology and genomic profiling have led to the identification of several genetic aberrations and tumor characteristics that allow for distinct subgroups of metastatic CRC (mCRC) with both prognostic and predictive implications. One of these

first evidence of treatment ≥4 months from their advanced diagnosis date. Patient attrition is shown in supplemental eTable 1 (available with this article at JNCCN.org ). Construction of Variables Clinical characteristics included demographics

. Research staff collected information about cancer diagnosis, oral therapy type, and other clinical characteristics from the EHR. Electronic Adherence Monitoring Participants were asked to store their oral therapy medication in pill bottles with electronic

with patient characteristics, these profiles ensure that targeted therapies are selectively applied in delivering patient-centered care. A shining example of this has been the incorporation of trastuzumab for cancers that overexpress HER2, the use of